US doctors probing if COVID is to blame for ‘unusual’ spike in cancer after pandemic
SUMMARY
A group of US doctors and scientists is investigating a potential link between COVID-19 and an unusual surge in rare, deadly cancers post-pandemic. Led by oncologist Kashyap Patel, who has observed an alarming increase in cases, the team is collecting patient data and advocating for a national registry to track trends. They suspect COVID-19’s widespread inflammation and organ infection may trigger cancer stem cell development. Despite a rise in aggressive cancers, some experts attribute this to healthcare disruptions during the pandemic. Researchers urge federal prioritization of this study, warning that long-term effects of repeated COVID-19 infections could be significant.